A series of monoquarternary piperazium salts including a structure of a formula IV have provided. In formula IV, -RX has defined in the specification. The monoquarternary piperazium salt of KMUP-3 disclosed in the present invention is characterized by being presented in a pro-drug form and having various pharmaceutical functions.